Physician
Gleckel, Melissa
Gleckel, Melissa was paid $198K by Medicaid between Aug 2020 and Oct 2022, across 12 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 86% of everything it billed.
33Billing provider infoGLECKEL, MELISSA
WORCESTER, MA 01605
WORCESTER, MA 01605
33aNPI1194145037assigned 04/18/2014
33bProvider typeFamily Medicine Physician
28Total paid$198K
24GClaims1,645
24DCodes billed12
24AFirst – last monthAug 2020 – Oct 2022
Compared with peers
Next to other Family Medicine Physician providers in Massachusetts
Rank by total paid#92 of 744
Median peer was paid$10K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 70 | $1K | |
| 2021 | 900 | $110K | |
| 2022 | 675 | $86K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 86% | 1,067 | 1,044 | $170K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.6% | 130 | 125 | $7K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.7% | 138 | 128 | $5K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.5% | 59 | 51 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 31 | 24 | $2K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 26 | 26 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 41 | 38 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 25 | 25 | $1K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 70 | 67 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 31 | 24 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 12 | 12 | $804.58 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | 14 | $733.92 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.